This proposal examines the general hypothesis that the neuropeptides substance P (SP) and calcitonin-gene related peptide (CGRP) act in a co-operative fashion to induce neurogenic inflammation of the intestine. The previous grant defined the mechanisms by which SP interacts with the neurokinin 1 receptor (NK1R) to initiate inflammation. Degradation of SP by the cell surface-enzyme neutral endopeptidase (NEP) and desensitization of the NK 1 R by Beta-arrestins, were found to terminate signaling by SP. In the current proposal, a combination of studies in transfected cell lines, endothelial cells that naturally express the receptors, and knockout mice that lack the peptides, their receptors, NEP and p-arrestins will be used to define novel mechanisms of neurogenic inflammation.
Aim 1 will define whether a complex of calcitonin receptor like receptor (CRLR) and receptor activity modifying protein (RAMP) 1 form a functional CGRP receptor that mediates the proinflammatory effects of CGRP. The mechanism and function of trafficking of CRLR/RAMP1 to and from the plasma membrane will be investigated by expression of dominant negative mutants of dynamin and rab GTPases that are required for vesicular transport. The cellular distribution of CRLR and RAMP1 will be defined in the intestine to ascertain whether the proteins are suitably located to comprise a functional CGRP receptor.
Aim 2 will define importance of beta-arrestins in mediating endocytosis and desensitization of NK1R and CRLR/RAMP1 in cell lines by expressing dominant negative mutants. The role of Beta-arrestins in terminating the inflammatory effects of SP and CGRP will be examined in vivo using Beta-arrestins 1 and 2 knockout animals.
Aim 3 will investigate novel mechanisms that account for the potentiating proinflammatory interactions between CGRP and SR The capacity of CGRP to inhibit the degradation of SP by NEP and thereby potentiate its proinflammatory effects will be evaluated in vitro and in the intact animal. Preliminary observations have identified a novel mechanism by which the SP induces sequestration of beta-arrestins into endosomes, thereby depleting cytosolic pools of beta-arrestins and attenuating endocytosis and desensitization of other receptors. The importance of this sequestration in potentiating CGRP signaling will be examined to determine whether this process could also account for the potentiating interactions of SP and CGRP. Together, the results of these experiments will provide new insights into peptide signaling, generate novel information about mechanisms of intestinal inflammation, and suggest new strategies for therapy.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK052388-07
Application #
6872879
Study Section
General Medicine A Subcommittee 2 (GMA)
Program Officer
Hamilton, Frank A
Project Start
1997-06-01
Project End
2007-02-28
Budget Start
2005-03-01
Budget End
2006-02-28
Support Year
7
Fiscal Year
2005
Total Cost
$191,743
Indirect Cost
Name
University of California San Francisco
Department
Surgery
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Vergnolle, N; Cenac, N; Altier, C et al. (2010) A role for transient receptor potential vanilloid 4 in tonicity-induced neurogenic inflammation. Br J Pharmacol 159:1161-73
Lennerz, Jochen K; Ruhle, Victor; Ceppa, Eugene P et al. (2008) Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution. J Comp Neurol 507:1277-99
Cottrell, Graeme S; Amadesi, Silvia; Pikios, Stella et al. (2007) Protease-activated receptor 2, dipeptidyl peptidase I, and proteases mediate Clostridium difficile toxin A enteritis. Gastroenterology 132:2422-37
Gazzieri, David; Trevisani, Marcello; Springer, Jochen et al. (2007) Substance P released by TRPV1-expressing neurons produces reactive oxygen species that mediate ethanol-induced gastric injury. Free Radic Biol Med 43:581-9
Cottrell, Graeme S; Padilla, Benjamin; Pikios, Stella et al. (2007) Post-endocytic sorting of calcitonin receptor-like receptor and receptor activity-modifying protein 1. J Biol Chem 282:12260-71
Lessard, A; Grady, E F; Bunnett, N W et al. (2007) Predominant surface distribution of neurokinin-3 receptors in non-dopaminergic dendrites in the rat substantia nigra and ventral tegmental area. Neuroscience 144:1393-408
Clifton, Matthew S; Hoy, Julia J; Chang, Jen et al. (2007) Role of calcitonin receptor-like receptor in colonic motility and inflammation. Am J Physiol Gastrointest Liver Physiol 293:G36-44
Wick, Elizabeth C; Pikios, Stella; Grady, Eileen F et al. (2006) Calcitonin gene-related peptide partially mediates nociception in acute experimental pancreatitis. Surgery 139:197-201
Wick, Elizabeth C; Hoge, Steven G; Grahn, Sarah W et al. (2006) Transient receptor potential vanilloid 1, calcitonin gene-related peptide, and substance P mediate nociception in acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 290:G959-69
Cottrell, Graeme S; Padilla, Benjamin; Pikios, Stella et al. (2006) Ubiquitin-dependent down-regulation of the neurokinin-1 receptor. J Biol Chem 281:27773-83

Showing the most recent 10 out of 31 publications